Home / Immunoglobulins, Normal Human, for Intravascular Adm. / Spain
ES ATC J06BA02 · updated 2 Nov 2026
Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Spain
Is there an Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Spain?
Yes. As of 2 Nov 2026, 9 Immunoglobulins, Normal Human, for Intravascular Adm. products are reported short in Spain, the first since 23 Sep 2025. The company estimate for the return is 30 Dec 2026 (latest 14 Mar 2027). Main reason: not stated.
Also short in Italy, Austria, Belgium, Switzerland, Sweden. All countries.
Affected products in Spain
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| ES | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 200 ml | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | 23 Sep 2025 | 14 Mar 2027 | Not stated |
| ES | IQYMUNE 100 MG/ML SOLUCION PARA PERFUSION, 1 vial de 100 ml | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | 30 Sep 2025 | 14 Mar 2027 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 100 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 20 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 200 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 50 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 100 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 200 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
| ES | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 50 ml | Octapharma S.A. | 6 Jul 2026 | 30 Dec 2026 | Not stated |
Source
AEMPS (Spanish Agency of Medicines and Medical Devices), CIMA. Official list. All authorised presentations with a declared supply problem.